Results 11 to 20 of about 8,720,515 (246)

Portal Vein Thrombosis [PDF]

open access: yesCase Reports in Vascular Medicine, 2015
Portal vein thrombosis (PVT) is the blockage or narrowing of the portal vein by a thrombus. It is relatively rare and has been linked with the presence of an underlying liver disease or prothrombotic disorders.
Ronny Cohen   +4 more
doaj   +9 more sources

Melioidosis with Portal Vein Thrombosis [PDF]

open access: yesCase Reports in Infectious Diseases, 2017
Melioidosis, caused by Burkholderia pseudomallei, is a common infectious disease in tropical regions. The author reports a case of melioidosis with a rare manifestation of portal vein thrombosis and cavernous transformation of the portal vein ...
Thanyaporn Direksunthorn
doaj   +4 more sources

PORTAL VEIN THROMBOSIS-ULTRASOUND IMAGING [PDF]

open access: yesSanamed, 2016
Portal venous system, apart from the main portal vein, includes its tributaries: superior and inferior mesenteric vein, as well as splenic vein, so the term portal venous thrombosis encompasses a broad spectrum of pathological conditions. Usually, one or
Trajkovska Meri   +3 more
doaj   +2 more sources

Diagnosis and Management of Portal Vein Thrombosis in Liver Cirrhosis [PDF]

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Portal vein thrombosis is formation of thrombus in main portal vein and its branches, that may also affect superior or mesenteric veins. Rebalanced coagulation system and changes in hepatic portal venous flow augment risk of portal vein thrombosis ...
Cynthia Kurniawan   +1 more
doaj   +2 more sources

Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?

open access: yesGastroenterology Review, 2022
Portal vein thrombosis is a common complication associated with malignancies such as hepatocellular carcinoma, with a dismal and negative impact on prognosis.
Nikolaos Benatatos   +9 more
doaj   +2 more sources

Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification

open access: yesThe Saudi Journal of Gastroenterology, 2015
Extrahepatic portal vein obstruction is a vascular disorder of liver, which results in obstruction and cavernomatous transformation of portal vein with or without the involvement of intrahepatic portal vein, splenic vein, or superior mesenteric vein ...
Zeeshan A Wani   +3 more
doaj   +2 more sources

Portal vein thrombosis

open access: yesEmergency Care Journal, 2005
Acute portal vein thrombosis (PVT) is un uncommon disease that can be seen in the Emergency Department. In the emergency department setting the diagnosis is difficult because of the variety of clinical presentation but in some clinical presentation ...
Gian Mario Santamaria   +4 more
doaj   +2 more sources

Portal Vein Thrombosis in Cirrhosis [PDF]

open access: yesJournal of Clinical and Experimental Hepatology, 2022
Patients with cirrhosis of the liver are at high risk of developing portal vein thrombosis (PVT), which has a complex, multifactorial cause. The condition may present with a myriad of symptoms and can occasionally cause severe complications. Contrast-enhanced computed tomography (CT) is the gold standard for the diagnosis of PVT.
Akash Shukla, Suprabhat Giri
openaire   +2 more sources

Genetic predisposition to porto‐sinusoidal vascular disorder: A functional genomic‐based, multigenerational family study

open access: yesHepatology, EarlyView., 2022
A deleterious variant of FCHSD1 results in mTOR pathway overactivation and may cause porto‐sinusoidal vascular disorder (PSVD). The pedigree of the family demonstrated an autosomal dominant disease with variable expressivity. Whole‐genome sequencing and Sanger sequencing both validated the existence of the FCHSD1 variant and the heterozygosity of c ...
Jingxuan Shan   +19 more
wiley   +1 more source

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

open access: yesHepatology, EarlyView., 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy